Egg Donation: Risks, Side Effects, and Long-Term Health Effects

Is being an egg donor harmful? How will your body feel after hormonal stimulation? Will you still be able to get pregnant in the future? These are questions worth discussing before starting a program.

According to the UK's fertility regulator, the HFEA, most donors don't experience health problems beyond discomfort during stimulation and egg retrieval. At the same time, donation remains a medical procedure with possible complications.

To assess its consequences, it's important to distinguish between temporary side effects, complications that require treatment, and long-term health questions. These are different things — and the answers to them carry different levels of certainty.

During stimulation, medication helps several follicles develop in the ovaries. During this period, bloating, a feeling of heaviness or discomfort in the lower abdomen, headaches, or nausea are possible. Not every donor experiences all of these symptoms.

Depending on the treatment regimen, some medications can also cause irritability, headaches, or sudden hot flashes.

These sensations on their own don't mean lasting harm to your health. But they shouldn't be hidden or judged only against other women's experiences. Tell the clinic about any change in how you feel — the doctor needs to weigh your symptoms together with the monitoring results.

Before starting a program, ask what reactions to expect specifically from the medications you'll be prescribed. It's also useful to know who to call between scheduled visits.

After retrieval, moderate cramping similar to menstrual cramps and light spotting are possible. These can last roughly 24–72 hours. Spotting should gradually decrease, not get heavier. The next period often starts within two weeks of the procedure.

Recovery after egg donation shouldn't be judged by the calendar alone. If pain gets worse, a fever develops, or you feel noticeably worse, you need to contact the medical team, even if very little time has passed since the retrieval.

Ask for written guidance on returning to work, physical activity, and sex life. Also confirm which pain relievers you can take and when a follow-up exam is needed.

Contraception should be discussed before stimulation even begins. A donation program doesn't protect against natural conception — appropriate contraception, agreed with your doctor, is needed throughout it.

Ovarian hyperstimulation syndrome (OHSS) is an excessive response of the body to stimulation. The ovaries enlarge, and fluid can build up in the abdominal cavity. The condition ranges in severity: mild cases often resolve on their own, while severe cases require specialized care, sometimes hospitalization.

The likelihood of OHSS isn't the same for everyone. The doctor assesses it based on ovarian reserve markers, follicle count, previous responses to stimulation, and other individual factors. High AMH or an expected strong ovarian response call for particular attention to prevention.

Prevention relies on individualized medication doses and the choice of protocol. The medication used for final egg maturation — the trigger shot — also matters: using a GnRH agonist trigger in appropriate protocols significantly lowers OHSS risk.

The updated 2025 ESHRE guidelines include a dedicated section for donors. It calls for individualized dosing and recommends a GnRH agonist trigger in defined stimulation regimens.

You don't need to work out all the drug names yourself. Instead, it's worth asking your doctor a specific question: "How are you assessing my hyperstimulation risk, and what will you do to reduce it?"

A good answer should relate to your own test results and treatment plan, not just a general statement about the procedure being safe.

Egg retrieval and anesthesia also carry possible complications, including infection, internal bleeding, ovarian torsion, and reactions to anesthesia. ASRM estimates the rate of serious acute complications — including infection, bleeding, and torsion — at under 0.5%. This is not the combined rate of all side effects, and it is not an estimate of OHSS risk.

Knowing about these conditions is mainly so you understand in advance how to get help. Ask who will be responsible for monitoring you after the procedure, where to go outside working hours, and how further treatment would be arranged if needed.

Before starting a program, save the clinic's number for urgent contact. Don't delay a medical assessment if, after stimulation or retrieval, you develop: severe or worsening abdominal pain, significant bloating, or repeated vomiting; shortness of breath, chest pain, fainting, or a noticeable drop in urine output; a fever, or heavy or worsening bleeding.

For shortness of breath, fainting, severe pain, or significant bleeding, seek emergency care rather than waiting for a coordinator to reply in a messaging app.

You don't need to work out the cause of your symptoms yourself. Your job is to report what's happening and get a timely doctor's assessment.

Available evidence doesn't show that donation on its own necessarily reduces ovarian reserve. Stimulation supports the development of follicles, some of which would otherwise have stopped developing anyway. So retrieving several eggs in one cycle isn't the same as "spending several years of fertility." At the same time, there isn't enough long-term data on repeated donations to give absolute guarantees.

There is also research on pregnancies after participating in programs. In a survey of former donors published in 2012, 60 women reported trying to conceive after donation; 57 of them became pregnant without fertility treatment. That's an encouraging result, but a small survey can't determine any individual woman's chances or rule out rare consequences.

So it's inaccurate to answer questions about egg donation and infertility with either "you won't be able to have children afterward" or "your future pregnancy is guaranteed."

AMH and ultrasound measurements help assess the ovaries' response to stimulation, but they don't give a complete forecast of future fertility. If you're planning a pregnancy, discuss those plans with a reproductive specialist before participating in a program.

The long-term effects of egg donation are less thoroughly studied than the course of stimulation and recovery after retrieval. New studies need to be evaluated based on exactly who was observed and whether the cause of any detected differences can be established.

For example, a Swedish study published in September 2026 followed the health of 170 former donors. Compared with a control group, they used outpatient care more often, were prescribed medication more often, and had somewhat higher rates of certain diagnoses, including genitourinary conditions. Hospitalization rates didn't differ.

This study doesn't prove that donation caused these differences. Some of the health differences existed before donation, and how people sought care may also have played a role. The authors emphasize the need for careful screening and continued follow-up.

The practical takeaway is not to avoid donation purely because of this uncertainty, but also not to treat pre-program screening as a lifelong health guarantee. The decision requires an assessment of your own situation, and after the program it's important to keep your medical records and tell future doctors about the stimulation cycles you've undergone.

Per ASRM's 2024 guidance, available data don't show a convincing link between fertility medications and breast cancer. For some other tumors, including ovarian tumors, a possible small increased risk has been described. However, it's difficult to separate the effect of treatment from infertility, endometriosis, and other factors.

An important caveat: much of this data concerns patients being treated for infertility, not healthy donors. Results can't automatically be carried over from one group to the other. There still isn't enough research specifically on donors to definitively answer every long-term safety question.

If you or your close relatives have had cancer, disclose this during screening. Discussing family history is part of the donor assessment, not a formality on a form.

The Ukrainian Procedure recommends no more than eight controlled stimulation attempts in total, with a repeat attempt no sooner than two months later. ASRM advises limiting donation to six cycles, given the possible cumulative risk. These are different recommendations, not interchangeable rules.

Neither limit means a given number of programs is automatically right for every woman. An individual assessment is needed before participating again. Tell your doctor about all previous donations, including any done at other clinics.

Ask that your discharge summary record the names and doses of medications, how the stimulation went, the retrieval outcome, and post-procedure recommendations. This information will help you discuss future decisions on more than just memory.

Donation has a personal side as well as a medical one. Before starting a program, give yourself time to think through the possibility that a child genetically related to you may be born, your own boundaries around privacy, and how you feel about potential future contact. ASRM recommends psychological counseling for donors, specifically to discuss these issues.

Counseling can be a space where you don't have to project confidence or give the "right" answers. You can talk about doubts, motivation, support from loved ones, and what you still need in order to decide.

Also ask what psychological support is available after the program, not just during screening.

A few specific questions are enough for a first conversation: "Why does this protocol suit me specifically?" — ask for an answer tied to your own test results, not just a standard regimen. "How are you reducing my hyperstimulation risk?" — clarify how your ovarian response will be monitored and under what circumstances the plan would change. "Who will follow up with me after retrieval?" — it matters to know the schedule of follow-up contacts and how to reach someone outside working hours. "How is help organized if I need it?" — ask for a written explanation of where treatment would be provided and who would cover the cost.

You don't need to decide during the first consultation. You can ask for further explanation or a second opinion from another reproductive specialist.

Your decision shouldn't rest on fear or on a promise that there's no risk at all. What matters is understanding what the program means for you specifically, and knowing what support you can count on.